Search

Search Constraints

You searched for: Author/Creator Naumann-Winter, Frauke

Search Results

1. Assessment of significant benefit for orphan medicinal products by European regulators may support subsequent relative effectiveness assessments by health technology assessment organizations. Issue 7 (July 2020)

2. Comparative analysis of the scope of European Union paediatric investigation plans with corresponding orphan designations. Issue 5 (31st October 2017)

3. Demonstrating significant benefit of orphan medicines: analysis of 15 years of experience in Europe. Issue 1 (January 2018)

4. Erratum to: Establishing medical plausibility in the context of orphan medicines designation in the European Union. Issue 1 (December 2015)